SPINAL SINGULARITY, INC.

Profile

Company Names

SPINAL SINGULARITY, INC.

Addresses

105 AVENIDA DE LA ESTRELLA, SUITE 3, SAN CLEMENTE, CA 92672

105 AVENIDA DE LA ESTRELLA, SUITE 3, SAN CLEMENTE, CA 92672

Phone Numbers

949.590.0555
470-222-5323

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2015

State Incorporated:

DELAWARE

Total Amount Raised:

$4,924,839.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2018-03-19 
$1,996,108.00 
$2,000,000.00 
$3,892.00 
Equity 
1
2016-12-15 
$2,928,731.00 
$5,239,995.00 
$2,311,264.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
KENNETH 
 
BAKER 
DIRECTOR
NEURAL ANALYTICS, INC.   |  AGENCY FOR STUDENT HEALTH RESEARCH INC.   |  SPINAL SINGULARITY, INC.   |  NEURVANA MEDICAL, LLC   |  M ARTHUR GENSLER JR + ASSOCIATES INC   |  ASHLEY PLACE APARTMENTS LLC
BILL 
 
COLONE 
EXECUTIVE OFFICER, DIRECTOR
SPINAL SINGULARITY, INC.   |  SINGLE PASS, INC.
ANDREW 
 
GILBERT 
DIRECTOR
CELADON COMMODITIES FUND, LTD.   |  INDIGO OPPORTUNITY FUND, LTD.   |  INDIGO OPPORTUNITY FUND, LP   |  VIRIDIAN FUND LTD   |  VIRIDIAN FUND, LTD.   |  VIRIDIAN FUND, LP   |  CRIMSON PHYSICAL COMMODITIES FUND, LP   |  CRIMSON PHYSICAL COMMODITIES FUND, LTD.   |  CELADON COMMODITIES FUND, LP   |  WEARWARE, INC.   |  GRANITE HOLDINGS, INC.   |  ASCENT BANCORP   |  SPINAL SINGULARITY, INC.   |  CRAXEL, INC.   |  WAM TACTICAL FUND I, LP   |  ECP V (CALIFORNIA CO-INVEST), LP   |  ECP INFRASTRUCTURE VI-C OFFSHORE FEEDER, LP   |  ECP VI-D, LP   |  ECP VI-C, LP   |  ECP VI-B, LP   |  ECP VI, LP
DEREK 
 
HERRERA 
EXECUTIVE OFFICER, DIRECTOR
SPINAL SINGULARITY, INC.   |  BRIGHT URO, INC.
CHRISTOPHER 
 
JENNINGS 
DIRECTOR
SPINAL SINGULARITY, INC.
DAVID 
 
KAYSEN 
DIRECTOR
AMERICAN TELECARE INC   |  PROUROCARE MEDICAL INC.   |  INTERRAD MEDICAL, INC.   |  SPINAL SINGULARITY, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2018-05-22
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-03-19 
2018-04-02
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-03-19 
2017-09-27
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-12-15 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#